ACADIA PHARMACEUTICALS INC (ACAD) › Shareholders' EquityACADIA PHARMACEUTICALS INC (ACAD) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $52.99M2009: $12.11M2010: $29.69M2011: $23.36M2012: $84.98M2013: $182.13M2014: $309.49M2015: $199.76M2016: $518.41M2017: $335.29M2018: $479.08M2019: $699.13M2020: $627.01M2021: $540.89M2022: $400.41M2023: $431.75M2024: $732.79M2025: $1.23B$1.23B2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$1.23B+67.5%2024$732.79M+69.7%2023$431.75M+7.8%2022$400.41M-26.0%2021$540.89M-13.7%2020$627.01M-10.3%2019$699.13M+45.9%2018$479.08M+42.9%2017$335.29M-35.3%2016$518.41M+159.5%2015$199.76M-35.5%2014$309.49M+69.9%2013$182.13M+114.3%2012$84.98M+263.8%2011$23.36M-21.3%2010$29.69M+145.1%2009$12.11M-77.1%2008$52.99M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share